Andreas Möller

14PUBLICATIONS
42CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Electrical energy generation (incl. renewables, excl. photovoltaics)Condensed matter characterisation technique developmentTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 03, 2026
Translational Opportunity of Engineered IFNγ-eEVs Through Targeted Inhibition of JAK/STAT1 Signaling, Mimicking IVIg Therapy.

|May 28, 2026
Impact of Isolation Techniques on the Content of Small Extracellular Vesicles.

|Nov 21, 2025
The (in)Significance of Establishing Accurate Extracellular Vesicle Nomenclature.

Sunyoung Ham, Luize G Lima, Andreas Möller

|Jun 19, 2024
Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling.

Li-Ying Wu, Su-Ho Park, Haakan Jakobsson

|Jan 18, 2024
Targeting the Oxytocin Receptor for Breast Cancer Management: A Niche for Peptide Tracers.

Predrag Kalaba, Cristina Sanchez de la Rosa, Andreas Möller

|Jan 18, 2023
An epithelial-to-mesenchymal transition induced extracellular vesicle prognostic signature in non-small cell lung cancer.

Richard J Lobb, Kekoolani S Visan, Li-Ying Wu

Pageof 3

Frequent Collaborators

3 joint publications

Richard Lobb

2 joint publications

Markus Muttenthaler

2 joint publications

Li-Ying Wu

1 joint publications

Huiping Liu